Bellwether Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-189
Closed -$13K 424
2025
Q2
$13K Buy
+189
New +$12.9K ﹤0.01% 345
2023
Q2
Sell
-106
Closed -$8.43K 321
2023
Q1
$8.43K Hold
106
﹤0.01% 283
2022
Q4
$7.17K Hold
106
﹤0.01% 290
2022
Q3
$5K Hold
106
﹤0.01% 325
2022
Q2
$5K Hold
106
﹤0.01% 282
2022
Q1
$5K Hold
106
﹤0.01% 368
2021
Q4
$5K Hold
106
﹤0.01% 405
2021
Q3
$5K Hold
106
﹤0.01% 371
2021
Q2
$4K Hold
106
﹤0.01% 342
2021
Q1
$3K Hold
106
﹤0.01% 331
2020
Q4
$3K Buy
+106
New +$3.66K ﹤0.01% 293

Other funds holding NVO

Bellwether Advisors's NVO Position: Q3 2025 in Review

Bellwether Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 189 shares — an estimated $13K sold.

Bellwether Advisors first reported a position in NVO in Q4 2020 and held it in 11 quarters. The position peaked at $13K in Q2 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Bellwether Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Bellwether Advisors sold 189 Novo Nordisk shares in Q3 2025, an estimated $13K.
  • Bellwether Advisors first reported a position in Novo Nordisk in Q4 2020 and held it in 11 quarters.
  • Bellwether Advisors's Novo Nordisk position peaked at $13K in Q2 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.